VOLGA

Drug: N/A

Company: AstraZeneca

Trial Phase: Phase III

Latest Updates

Treatment Arm Intervention Regimen Event-Free Survival (EFS) Outcome Overall Survival (OS) Outcome Safety Profile
Arm 1 (Triplet) Perioperative Imfinzi + Imjudo + Neoadjuvant EV Statistically significant & clinically meaningful improvement Favorable directional trend (not yet statistically significant) Consistent with known individual profiles; no new signals
Arm 2 (Doublet) Perioperative Imfinzi + Neoadjuvant EV Statistically significant & clinically meaningful improvement Statistically significant & clinically meaningful improvement Consistent with known individual profiles; no new signals
Arm 3 (Control) Radical Cystectomy ± approved adjuvant therapy Standard of care baseline Standard of care baseline Standard surgical risk baseline

Discover More